OrthoPediatrics Statistics Share Statistics OrthoPediatrics has 24.77M
shares outstanding. The number of shares has increased by 2.29%
in one year.
Shares Outstanding 24.77M Shares Change (YoY) 2.29% Shares Change (QoQ) 1.99% Owned by Institutions (%) 71.85% Shares Floating 16.59M Failed to Deliver (FTD) Shares 2,332 FTD / Avg. Volume 1.54%
Short Selling Information The latest short interest is 1.12M, so 4.52% of the outstanding
shares have been sold short.
Short Interest 1.12M Short % of Shares Out 4.52% Short % of Float 6.73% Short Ratio (days to cover) 9.49
Valuation Ratios The PE ratio is -14.14 and the forward
PE ratio is -18.07.
OrthoPediatrics's PEG ratio is
-0.18.
PE Ratio -14.14 Forward PE -18.07 PS Ratio 2.61 Forward PS 1.7 PB Ratio 1.51 P/FCF Ratio -12.95 PEG Ratio -0.18
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for OrthoPediatrics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.98,
with a Debt / Equity ratio of 0.21.
Current Ratio 6.98 Quick Ratio 3.54 Debt / Equity 0.21 Debt / EBITDA -7 Debt / FCF -1.77 Interest Coverage -11.26
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $364.28K Profits Per Employee $-67.3K Employee Count 562 Asset Turnover 0.43 Inventory Turnover 0.48
Taxes Income Tax -4.11M Effective Tax Rate 9.8%
Stock Price Statistics The stock price has increased by -26.96% in the
last 52 weeks. The beta is 1.12, so OrthoPediatrics's
price volatility has been higher than the market average.
Beta 1.12 52-Week Price Change -26.96% 50-Day Moving Average 21.34 200-Day Moving Average 23.33 Relative Strength Index (RSI) 35.91 Average Volume (20 Days) 151,488
Income Statement In the last 12 months, OrthoPediatrics had revenue of 204.73M
and earned -37.82M
in profits. Earnings per share was -1.64.
Revenue 204.73M Gross Profit 148.6M Operating Income -29.52M Net Income -37.82M EBITDA -10.44M EBIT -29.52M Earnings Per Share (EPS) -1.64
Full Income Statement Balance Sheet The company has 43.82M in cash and 73.12M in
debt, giving a net cash position of -29.3M.
Cash & Cash Equivalents 43.82M Total Debt 73.12M Net Cash -29.3M Retained Earnings -235.56M Total Assets 503.61M Working Capital 219.04M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -27.05M
and capital expenditures -14.26M, giving a free cash flow of -41.31M.
Operating Cash Flow -27.05M Capital Expenditures -14.26M Free Cash Flow -41.31M FCF Per Share -1.79
Full Cash Flow Statement Margins Gross margin is 72.58%, with operating and profit margins of -14.42% and -18.47%.
Gross Margin 72.58% Operating Margin -14.42% Pretax Margin -20.48% Profit Margin -18.47% EBITDA Margin -5.1% EBIT Margin -14.42% FCF Margin -20.18%
